Is Pomegranate Seed Oil Postprandial Lipemia Endothelial Function Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Pomegranate Seed Oil Postprandial Lipemia Endothelial Function Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Hormonal changes associated with this stage of life contribute to a higher CVD risk, driven by factors such as visceral obesity, atherogenic dyslipidemia, vascular dysfunction, and high blood pressure (BP). [Almoraie Manal M (2026); evidence level 2] - However, a direct association between menopause and increased risk of CVD events has only been confirmed in cases of early (premature) menopause [,]. [Almoraie Manal M (2026); evidence level 2] - Non-fasting triacylglycerol (TAG) concentrations are an independent, modifiable CVD risk factor [,], and considered more discriminatory of risk than fasting concentrations in women [,,]. [Almoraie Manal M (2026); evidence level 2] - 1 1 2 3 4 [5] [6] [7] [8] [9] [10] 4 8 11 12 13 11 14 15 [16] [17] [18] 19 Cardiovascular diseases (CVD) are a significant concern in females transitioning to menopause []. [Almoraie Manal M (2026); evidence level 2] - Since the early 20th century, the increase in non-communicable diseases such as diabetes, heart disease, stroke, and cancer compared to infectious diseases has led to chronic illnesses becoming a leading cause of global morbidity and mortality [...]. [Noubissi FK (2024); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.